Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD)-Reference-Cited by-同舟云学术

Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD)

Published:2013-03-28 Issue:3 Volume:8 Page:e58358
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gabrielli Federico,Salvi Roberto,Garulli Chiara,Kalogris Cristina,Arima Serena,Tardella Luca,Monaci Paolo,Pupa Serenella M.,Tagliabue Elda,Montani Maura,Quaglino Elena,Stramucci Lorenzo,Curcio Claudia,Marchini Cristina,Amici Augusto

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab;HS Cho;Nature,2003

2. The biology of erbB-2/neu/HER-2 and its role in cancer;NE Hynes;Biochem Biophys Acta Rev Cancer,1994

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;DJ Slamon;Science,1987

4. Treatment of HER2-positive breast cancer: current status and future perspectives;CL Arteaga;Nat Rev Clin Oncol,2011

5. Existent T cell and antibody immunity to Her-2/neu protein in patients with breast cancer;ML Disis;Cancer Res,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT6 promotes metastasis and relapse in HER2-positive breast cancer;Scientific Reports;2023-12-12

2. Domain-level epitope mapping of polyclonal antibodies against HER-1 and HER-2 receptors using phage display technology;Scientific Reports;2022-07-18

3. Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology;Antibodies;2022-07-14

4. Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer;Cancer Immunology Research;2018-12

5. A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy;Human Vaccines & Immunotherapeutics;2015-04-15